| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 582.63B | 578.60B | 518.38B | 483.99B | 470.38B | 463.74B |
| Gross Profit | 85.39B | 81.06B | 59.13B | 58.00B | 64.30B | 59.15B |
| EBITDA | 41.64B | 41.74B | 28.09B | 31.26B | 40.18B | 37.03B |
| Net Income | 15.13B | 17.18B | 12.54B | 14.78B | 25.16B | 24.21B |
Balance Sheet | ||||||
| Total Assets | 474.13B | 537.74B | 519.96B | 436.75B | 435.79B | 358.75B |
| Cash, Cash Equivalents and Short-Term Investments | 58.82B | 53.48B | 50.04B | 32.48B | 50.93B | 44.76B |
| Total Debt | 89.53B | 127.49B | 117.09B | 61.11B | 59.98B | 10.13B |
| Total Liabilities | 211.56B | 267.86B | 259.87B | 182.45B | 186.54B | 127.43B |
| Stockholders Equity | 254.32B | 261.50B | 251.98B | 246.82B | 242.12B | 226.39B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 12.36B | 27.62B | -280.00M | 4.38B | 33.22B |
| Operating Cash Flow | 0.00 | 18.05B | 33.63B | 5.32B | 12.97B | 41.60B |
| Investing Cash Flow | 0.00 | -9.37B | -55.55B | -12.31B | -46.20B | 1.87B |
| Financing Cash Flow | 0.00 | -6.41B | 38.82B | -12.57B | 38.40B | -32.20B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥292.97B | 12.00 | 8.70% | 2.28% | 6.50% | 53.04% | |
76 Outperform | ¥246.39B | 12.19 | 7.43% | 2.78% | 1.31% | 59.20% | |
74 Outperform | ¥574.62B | 13.52 | 8.34% | 2.66% | 5.14% | 12.52% | |
72 Outperform | ¥1.21T | 12.95 | 14.94% | 2.00% | 16.43% | 53.76% | |
72 Outperform | ¥651.64B | 12.93 | ― | 2.15% | -5.20% | -1.20% | |
70 Outperform | ¥520.99B | 14.38 | ― | 2.51% | 15.47% | 64.50% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |